<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>4(11)</volume><submitter>Gruber M</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Atrial fibrillation (AF) increases heart failure (HF) risk. Whereas the risk of HF-related hospitalization and mortality are known in the setting of AF, the impact of AF treatment on HF development is understudied.&lt;h4>Objective&lt;/h4>The purpose of this study was to compare HF incidence among AF patients treated with antiarrhythmic drugs (AADs) vs catheter ablation (CA).&lt;h4>Methods&lt;/h4>AF patients with 1 prior AAD usage were identified in 2014-2022 Optum Clinformatics database. Patients were classified into 2 cohorts: those receiving CA vs those receiving a different AAD prescription. The 2 cohorts were matched on sociodemographic and clinical covariates using propensity score matching technique. Cox regression model was used to compare incident HF risk in the 2 cohorts. S</pubmed_abstract><journal>Heart rhythm O2</journal><pagination>681-691</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10685151</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Heart failure risk in patients with atrial fibrillation treated with catheter ablation vs antiarrhythmic drugs.</pubmed_title><pmcid>PMC10685151</pmcid><pubmed_authors>Karim S</pubmed_authors><pubmed_authors>Zhang D</pubmed_authors><pubmed_authors>Gruber M</pubmed_authors><pubmed_authors>Khanna R</pubmed_authors><pubmed_authors>Iglesias M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Heart failure risk in patients with atrial fibrillation treated with catheter ablation vs antiarrhythmic drugs.</name><description>&lt;h4>Background&lt;/h4>Atrial fibrillation (AF) increases heart failure (HF) risk. Whereas the risk of HF-related hospitalization and mortality are known in the setting of AF, the impact of AF treatment on HF development is understudied.&lt;h4>Objective&lt;/h4>The purpose of this study was to compare HF incidence among AF patients treated with antiarrhythmic drugs (AADs) vs catheter ablation (CA).&lt;h4>Methods&lt;/h4>AF patients with 1 prior AAD usage were identified in 2014-2022 Optum Clinformatics database. Patients were classified into 2 cohorts: those receiving CA vs those receiving a different AAD prescription. The 2 cohorts were matched on sociodemographic and clinical covariates using propensity score matching technique. Cox regression model was used to compare incident HF risk in the 2 cohorts. S</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2025-04-26T00:17:37.663Z</modification><creation>2025-04-06T09:41:09.463Z</creation></dates><accession>S-EPMC10685151</accession><cross_references><pubmed>38034885</pubmed><doi>10.1016/j.hroo.2023.09.009</doi></cross_references></HashMap>